🔗 Share this article

An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Material Removal

According to the social media company, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company said it was committed to keeping the service secure and investing in enhancing compliance measures.

Online Marketplace Operations

Research also found groups with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of users, filled with images of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.

After minutes of entering one group, a vendor shared contact information, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.

Item Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious medical dangers”.